BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
12.15
-0.10 (-0.82%)
Nov 7, 2025, 4:00 PM EST - Market closed

BBOT Analyst Ratings

Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$25.00
Upside
+105.76%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Leerink Partners
Leerink Partners
Buy
Initiates
$25
BuyInitiates$25+105.76%Sep 17, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$27
Strong BuyInitiates$27+122.22%Sep 15, 2025
Oppenheimer
Oppenheimer
Buy
Initiates
$23
BuyInitiates$23+89.30%Sep 4, 2025
Wedbush
Wedbush
Buy
Initiates
$25
BuyInitiates$25+105.76%Aug 18, 2025